BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,074,229 | -6.5% | 54,961 | +12.8% | 0.01% | 0.0% |
| Q2 2023 | $2,219,409 | -5.3% | 48,714 | -15.7% | 0.01% | 0.0% |
| Q1 2023 | $2,343,070 | -0.3% | 57,768 | +25.3% | 0.01% | -14.3% |
| Q4 2022 | $2,350,840 | +24.1% | 46,122 | +31.1% | 0.01% | +16.7% |
| Q3 2022 | $1,895,000 | -77.7% | 35,173 | -73.4% | 0.01% | -76.9% |
| Q2 2022 | $8,481,000 | -72.9% | 132,032 | -67.3% | 0.03% | -64.9% |
| Q1 2022 | $31,273,000 | -40.7% | 403,262 | -34.3% | 0.07% | -33.9% |
| Q4 2021 | $52,708,000 | +0.4% | 614,035 | -5.9% | 0.11% | -3.4% |
| Q3 2021 | $52,488,000 | -26.3% | 652,571 | -26.3% | 0.12% | -26.6% |
| Q2 2021 | $71,255,000 | +42.5% | 885,159 | +49.4% | 0.16% | +28.5% |
| Q1 2021 | $49,987,000 | -26.0% | 592,665 | -29.6% | 0.12% | -30.9% |
| Q4 2020 | $67,556,000 | -19.3% | 841,922 | -19.1% | 0.18% | -31.3% |
| Q3 2020 | $83,719,000 | -12.3% | 1,041,039 | -6.1% | 0.26% | -20.1% |
| Q2 2020 | $95,456,000 | +2.6% | 1,108,644 | -3.3% | 0.32% | -13.1% |
| Q1 2020 | $93,078,000 | -9.1% | 1,146,415 | -6.4% | 0.37% | +13.7% |
| Q4 2019 | $102,370,000 | -37.2% | 1,224,193 | -34.3% | 0.33% | -43.0% |
| Q3 2019 | $162,962,000 | +5.7% | 1,863,075 | -1.1% | 0.58% | +5.5% |
| Q2 2019 | $154,233,000 | -2.3% | 1,883,167 | -3.0% | 0.54% | -6.2% |
| Q1 2019 | $157,903,000 | +10.2% | 1,941,997 | -10.8% | 0.58% | -9.6% |
| Q4 2018 | $143,265,000 | -18.6% | 2,177,375 | -4.6% | 0.64% | -7.7% |
| Q3 2018 | $176,038,000 | +2.7% | 2,283,099 | -1.6% | 0.70% | -10.8% |
| Q2 2018 | $171,390,000 | +7.7% | 2,320,695 | -5.1% | 0.78% | +4.6% |
| Q1 2018 | $159,109,000 | -2.6% | 2,445,831 | -3.2% | 0.75% | -11.7% |
| Q4 2017 | $163,305,000 | +9.2% | 2,525,870 | +6.0% | 0.85% | -8.9% |
| Q3 2017 | $149,571,000 | +2.6% | 2,383,661 | -1.0% | 0.93% | -1.1% |
| Q2 2017 | $145,767,000 | +17.5% | 2,407,777 | +0.6% | 0.94% | +13.7% |
| Q1 2017 | $124,095,000 | +29.3% | 2,392,882 | +10.5% | 0.83% | +10.0% |
| Q4 2016 | $95,984,000 | +9.6% | 2,164,668 | +17.6% | 0.75% | +16.1% |
| Q3 2016 | $87,593,000 | +260.5% | 1,840,147 | +242.4% | 0.65% | +251.6% |
| Q2 2016 | $24,300,000 | +144.8% | 537,362 | +122.4% | 0.18% | +130.0% |
| Q1 2016 | $9,926,000 | +191.9% | 241,657 | +171.2% | 0.08% | +175.9% |
| Q4 2015 | $3,400,000 | +389.2% | 89,100 | +321.2% | 0.03% | +480.0% |
| Q3 2015 | $695,000 | -53.0% | 21,153 | 0.0% | 0.01% | -54.5% |
| Q2 2015 | $1,480,000 | -76.8% | 21,153 | -77.3% | 0.01% | -77.1% |
| Q1 2015 | $6,381,000 | -15.5% | 93,184 | -9.6% | 0.05% | -11.1% |
| Q4 2014 | $7,553,000 | +5.2% | 103,043 | +3.0% | 0.05% | +5.9% |
| Q3 2014 | $7,181,000 | -1.7% | 100,045 | -0.9% | 0.05% | -1.9% |
| Q2 2014 | $7,302,000 | +5.9% | 100,998 | +7.8% | 0.05% | -1.9% |
| Q1 2014 | $6,895,000 | +7.0% | 93,703 | +1.1% | 0.05% | -1.9% |
| Q4 2013 | $6,445,000 | +2.3% | 92,683 | -3.3% | 0.05% | -11.5% |
| Q3 2013 | $6,298,000 | -11.4% | 95,872 | -6.6% | 0.06% | -15.3% |
| Q2 2013 | $7,111,000 | – | 102,673 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |